课题基金 / 基金详情

IMMUNIZATION OF MACAQUES WITH SINGLE-CYCLE SIV AS NOVEL AIDS VACCINE APPROACH

IMMUNIZATION OF MACAQUES WITH SINGLE-CYCLE SIV AS NOVEL AIDS VACCINE APPROACH
使用单周期 SIV 作为新型艾滋病疫苗对猕猴进行免疫接种
批准号:
8357938
负责人:
David T Evans
金额:
$21.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30

项目摘要

项目成果

David T Evans的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Rhesus macaques were immunized with three different strains of single-cycle SIV that express envelope glycoproteins modified to lack structural features that interfere with the development of neutralizing antibodies to determine if enhancing envelope-specific antibody responses might improve the extent of protection afforded by this vaccine approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of didehydro-Cortistatin A as a block-and-lock agent for a functional HIV cure in a macaque model
  • 批准号:
    10403162
  • 项目类别:
  • 资助金额:
    $44.11万
  • 财政年份:
    2021
  • 负责人:
    David T Evans
  • 依托单位:
Evaluation of didehydro-Cortistatin A as a block-and-lock agent for a functional HIV cure in a macaque model
  • 批准号:
    10591883
  • 项目类别:
  • 资助金额:
    $45.09万
  • 财政年份:
    2021
  • 负责人:
    David T Evans
  • 依托单位:
Tethering lentiviral restriction to Fc-mediated antibody responses
  • 批准号:
    10425358
  • 项目类别:
  • 资助金额:
    $70.77万
  • 财政年份:
    2020
  • 负责人:
    David T Evans
  • 依托单位:
Tethering lentiviral restriction to Fc-mediated antibody responses
  • 批准号:
    10082732
  • 项目类别:
  • 资助金额:
    $45.44万
  • 财政年份:
    2020
  • 负责人:
    David T Evans
  • 依托单位:
海外基金